Patents by Inventor Thomas Nanninga

Thomas Nanninga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preparation of gamma-amino acids having affinity for the alpha-2-delta protein
    Publication number: 20070141684
    Abstract: Disclosed are materials and methods for preparing optically active ?-amino acids of Formula 1, which bind to the alpha-2-delta (?2?) subunit of a calcium channel.
    Type: Application
    Filed: December 8, 2006
    Publication date: June 21, 2007
    Inventors: Margaret Evans, Lloyd Franklin, Lorraine Murtagh, Thomas Nanninga, Bruce Pearlman, James Saenz, Niamh Willis
  • Polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
    Patent number: 7060856
    Abstract: This invention provides a novel polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide, as well a pharmaceutical compositions and therapeutic methods utilizing the polymorphic form.
    Type: Grant
    Filed: October 20, 2004
    Date of Patent: June 13, 2006
    Assignee: Warner-Lambert Company
    Inventors: Dainius Macikenas, Thomas Nanninga
  • Process for the synthesis of 1,3-diols
    Publication number: 20050197500
    Abstract: An improved process for the preparation of cis-1,3-diols is described where a beta hydroxy ketone is treated with a trialkylborane or dialkylalkoxyborane or a mixture of a trialkylborane and a dialkylalkoxyborane followed by recovery and reuse of the alkylborane species to convert additional beta hydroxy ketone to the cis-1,3-diol.
    Type: Application
    Filed: April 29, 2005
    Publication date: September 8, 2005
    Inventors: Robert Bosch, Richard McCabe, Thomas Nanninga, Robert Stahl
  • Polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
    Publication number: 20050085550
    Abstract: This invention provides a novel polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide, as well a pharmaceutical compositions and therapeutic methods utilizing the polymorphic form.
    Type: Application
    Filed: October 20, 2004
    Publication date: April 21, 2005
    Inventors: Dainius Macikenas, Thomas Nanninga